These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20095947)

  • 1. A limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous system.
    Zeier Z; Aguilar JS; Lopez CM; Devi-Rao GB; Watson ZL; Baker HV; Wagner EK; Bloom DC
    J Neurovirol; 2009 Sep; 15(5-6):411-24. PubMed ID: 20095947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector.
    Huard J; Akkaraju G; Watkins SC; Pike-Cavalcoli M; Glorioso JC
    Hum Gene Ther; 1997 Mar; 8(4):439-52. PubMed ID: 9054519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
    Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
    J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
    Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
    Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.
    Broberg EK; Peltoniemi J; Nygårdas M; Vahlberg T; Röyttä M; Hukkanen V
    J Virol; 2004 Dec; 78(23):13139-52. PubMed ID: 15542666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy.
    Bowers WJ; Olschowka JA; Federoff HJ
    Gene Ther; 2003 Jun; 10(11):941-5. PubMed ID: 12756414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication-Competent Controlled Herpes Simplex Virus.
    Bloom DC; Feller J; McAnany P; Vilaboa N; Voellmy R
    J Virol; 2015 Oct; 89(20):10668-79. PubMed ID: 26269179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
    Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
    J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector.
    Warden MP; Weir JP
    Virology; 1996 Dec; 226(1):127-31. PubMed ID: 8941330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
    Grant KG; Krisky DM; Ataai MM; Glorioso JC
    Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Recombinant HSV-Based Vaccine Vectors.
    Voellmy R; Bloom DC; Vilaboa N; Feller J
    Methods Mol Biol; 2017; 1581():55-78. PubMed ID: 28374243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of specific innate immune responses in herpes simplex virus infection of the central nervous system.
    Wang JP; Bowen GN; Zhou S; Cerny A; Zacharia A; Knipe DM; Finberg RW; Kurt-Jones EA
    J Virol; 2012 Feb; 86(4):2273-81. PubMed ID: 22171256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells.
    Halford WP; Kemp CD; Isler JA; Davido DJ; Schaffer PA
    J Virol; 2001 Jul; 75(13):6143-53. PubMed ID: 11390616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity.
    Lauterbach H; Ried C; Epstein AL; Marconi P; Brocker T
    J Gen Virol; 2005 Sep; 86(Pt 9):2401-2410. PubMed ID: 16099897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.
    Han F; Miyagawa Y; Verlengia G; Ingusci S; Soukupova M; Simonato M; Glorioso JC; Cohen JB
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific patterns of defective HSV-1 gene transfer in the adult central nervous system: implications for gene targeting.
    Wood MJ; Byrnes AP; Kaplitt MG; Pfaff DW; Rabkin SD; Charlton HM
    Exp Neurol; 1994 Nov; 130(1):127-40. PubMed ID: 7821388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene delivery using herpes simplex virus vectors.
    Burton EA; Fink DJ; Glorioso JC
    DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.
    Perez MC; Hunt SP; Coffin RS; Palmer JA
    Gene Ther; 2004 Jul; 11(13):1023-32. PubMed ID: 15164091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.